Skip to main content

Peer Review reports

From: Multicenter, randomized controlled, open label evaluation of the efficacy and safety of arbidol hydrochloride tablets in the treatment of influenza-like cases

Original Submission
20 Feb 2023 Submitted Original manuscript
11 Mar 2023 Author responded Author comments - Yingping Tian
13 Mar 2023 Author responded Author comments - Yingping Tian
Resubmission - Version 2
11 Mar 2023 Submitted Manuscript version 2
22 Mar 2023 Author responded Author comments - Yingping Tian
Resubmission - Version 3
22 Mar 2023 Submitted Manuscript version 3
4 May 2023 Reviewed Reviewer Report
4 May 2023 Reviewed Reviewer Report - Hamid Morovati
8 May 2023 Reviewed Reviewer Report
2 Aug 2023 Author responded Author comments - Yingping Tian
Resubmission - Version 4
2 Aug 2023 Submitted Manuscript version 4
2 Aug 2023 Author responded Author comments - Yingping Tian
Resubmission - Version 5
2 Aug 2023 Submitted Manuscript version 5
3 Aug 2023 Author responded Author comments - Yingping Tian
Resubmission - Version 6
3 Aug 2023 Submitted Manuscript version 6
20 Aug 2023 Reviewed Reviewer Report
27 Aug 2023 Reviewed Reviewer Report - Hamid Morovati
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
28 Aug 2023 Editorially accepted
6 Sep 2023 Article published 10.1186/s12879-023-08570-9

You can find further information about peer review here.

Back to article page